Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fluid management during neurosurgery presents a special clinical agenda. Volume overload can have detrimental effects on intracranial pressure by increasing either cerebral blood volume or hydrostatically driven cerebral edema formation. On the other hand, an overt restrictive fluid strategy may risk hemodynamic instability.
Recently, dynamic fluid responsiveness parameters such as stroke volume variation (SVV) have been shown as a more precise parameters for fluid management including in neurosurgical patients. The threshold of SVV is reported about 10-15%. In this study, the investigators aim to using two SVV threshold to conduct intraoperative fluid therapy for craniotomy. Randomization will be generated by computer sampling. One of the two groups of patients will be managed with fluid bolus to keep intraoperative SVV <10% presenting the "normovolemia" group. The other group of patients will be kept intraoperative SVV <18% which is slightly above previously reported SVV threshold upper limit. The second group thus presents the "restrictive" group. Clinical outcomes, laboratory analysis including S100-B for neuronal damage and neutrophil gelatinase-associated lipocalin (NGAL) for acute kidney injury, will be compared.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Normovolemic group (keeping SVV<10% in supine; <15% in prone) | Experimental |
|
|
| Restricitve group (keeping SVV < 18% in supine; <23% in prone) | Active Comparator |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intravenous colloid bolus with Voluven | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| serum S100B protein | Changes from preoperative to postoperative day 2 | |
| serum NGAL level | Changes from preoperative to postoperative day 2. |
| Measure | Description | Time Frame |
|---|---|---|
| Length of hospital stay | participants will be followed for the duration of hospital stay, an expected average of 3 to 4 weeks | |
| Postoperative complications rate | participants will be followed for the duration of hospital stay, an expected average of 3 to 4 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Cardiac dysfunction, such as coronary artery diseases; atrial fibrillation;
Renal dysfunction, eGFR< 60 ml.min-1.1.73m-2
Pulmonary cormorbidity, such as COPD
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chia-Chen Liu | Contact | +886-2-23123456 | 65521 | a0918994038@yahoo.com.tw |
| Name | Affiliation | Role |
|---|---|---|
| Chun-Yu Wu, MD | National Taiwan University Hospital Anesthesiology Department | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Taiwan University Hospital | Recruiting | Taipei | 100 | Taiwan |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28981592 | Derived | Wu CY, Lin YS, Tseng HM, Cheng HL, Lee TS, Lin PL, Chou WH, Cheng YJ. Comparison of two stroke volume variation-based goal-directed fluid therapies for supratentorial brain tumour resection: a randomized controlled trial. Br J Anaesth. 2017 Nov 1;119(5):934-942. doi: 10.1093/bja/aex189. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Total intraoperative intravenous fluid administrated | During the surgical time, an expected average of 3 to 5 hours |
| ID | Term |
|---|---|
| D015173 | Supratentorial Neoplasms |
| D001932 | Brain Neoplasms |
| ID | Term |
|---|---|
| D016543 | Central Nervous System Neoplasms |
| D009423 | Nervous System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C485123 | HES 130-0.4 |
Not provided
Not provided
Not provided